Background:
MCC-DM1 is a drug-Linker Conjugates for ADC such ad Anti-CD22-MCC-DM1[1].
[1]. Manu Lopus, et al. Antibody-DM1 conjugates as cancer therapeutics. Cancer Lett. 2011 Aug 28;307(2):113-8.